Main Menu
Menu

Council for Innovation Promotion

Publish Date
Resources
Government AgendaReports
Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2)

For the United States to maintain its competitive edge on the global stage, we must lead in innovation. This is only achievable...

Resources
Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: Second Edition

First released in 2024, the Congressional Innovation Scorecard assesses and rates how the U.S. Congress as a whole — and its individual...

Videos
The Patent Eligibility Restoration Act (PERA)
Videos
C4IP Patent Myth Video Series
Resources
Issue Briefs
Addressing Patent Myths

Activist groups routinely accuse companies of “abusing” the patent system by engaging in practices such as “royalty stacking,” “patent evergreening,” “product hopping,”...

Press Releases
Council for Innovation Promotion Statement on RALIA and the BIA

WASHINGTON (November 10, 2025) — Recently, Representatives Thomas Massie (R-KY), Marcy Kaptur (D-OH), Michael Cloud (R-TX), Warren Davidson (R-OH), Paul Gosar (R-AZ),...

Blog
This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

Blog
C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

News
C4IP Urges USTR to Use USMCA Joint Review to Address Shortcomings on IP Protections
IPWatchdog
Resources
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Resources
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025
Resources:

Resources:

The Congressional Innovation Scorecard: Second Edition,

06/10/2025
Videos:

Videos:

The Patent Eligibility Restoration Act (PERA),

05/01/2025
Videos:

Videos:

C4IP Patent Myth Video Series,

02/12/2025
Resources:

Resources:

Addressing Patent Myths,

12/19/2024
Press Releases:

Press Releases:

Council for Innovation Promotion Statement on RALIA and the BIA,

11/10/2025
Blog:

Blog:

This Month in IP: October 2025,

11/10/2025
Blog:

Blog:

C4IP Coalition Updates: October 2025,

11/10/2025
News:

News:

C4IP Urges USTR to Use USMCA Joint Review to Address Shortcomings on IP Protections,

11/07/2025
Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025
Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025
Blog:

Blog:

Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth,

11/03/2025
Scroll to Top